Genzyme MS portfolio clears two hurdles abroad


An EU regulatory body issued opinions that bode well for Lemtrada and Aubagio, and may positively impact other drugs in the category.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters